Search details
1.
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Eur Radiol
; 33(1): 512-522, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-35864351
2.
ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis.
Oncology
; 100(8): 419-428, 2022.
Article
in English
| MEDLINE | ID: mdl-35709702
3.
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience.
Ann Hematol
; 101(2): 349-358, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34766217
4.
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites.
Oncology
; 99(10): 652-658, 2021.
Article
in English
| MEDLINE | ID: mdl-34340231
5.
Solving the deficit of cancer pain management skills by education programs.
Support Care Cancer
; 29(4): 1843-1848, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-32779009
6.
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma.
Liver Int
; 39(11): 2184-2189, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31400295
7.
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma.
Int J Cancer
; 142(9): 1878-1889, 2018 05 01.
Article
in English
| MEDLINE | ID: mdl-29266245
8.
Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: a meta-analysis of randomized clinical trials.
Oncology
; 88(6): 345-52, 2015.
Article
in English
| MEDLINE | ID: mdl-25572912
9.
Recent advances in the prevention of hepatocellular carcinoma recurrence.
Semin Liver Dis
; 34(4): 427-34, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25369304
10.
Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy.
J Hepatol
; 60(2): 313-8, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24036008
11.
ß-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma.
Oncology
; 87(3): 159-66, 2014.
Article
in English
| MEDLINE | ID: mdl-25012536
12.
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 11: 1015-1029, 2024.
Article
in English
| MEDLINE | ID: mdl-38854818
13.
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma.
Cancer
; 119(6): 1210-6, 2013 Mar 15.
Article
in English
| MEDLINE | ID: mdl-23212657
14.
Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages.
Cell Mol Gastroenterol Hepatol
; 15(6): 1351-1369, 2023.
Article
in English
| MEDLINE | ID: mdl-36828281
15.
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment.
Hepatol Int
; 16(5): 1199-1207, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35986846
16.
Increasing incidence of brain metastasis in patients with advanced hepatocellular carcinoma in the era of antiangiogenic targeted therapy.
Oncologist
; 16(1): 82-6, 2011.
Article
in English
| MEDLINE | ID: mdl-21212425
17.
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance.
Exp Hematol Oncol
; 10(1): 45, 2021 Aug 16.
Article
in English
| MEDLINE | ID: mdl-34399826
18.
Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy.
Cancers (Basel)
; 13(20)2021 Oct 14.
Article
in English
| MEDLINE | ID: mdl-34680292
19.
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma.
Oncoimmunology
; 10(1): 1973710, 2021.
Article
in English
| MEDLINE | ID: mdl-34595057
20.
An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 8: 809-822, 2021.
Article
in English
| MEDLINE | ID: mdl-34336726